dmat
Showing 1 - 1 of 1
Dysferlinopathy, Miyoshi Myopathy, LGMDR2 Trial in Moscow
Enrolling by invitation
- Dysferlinopathy
- +3 more
-
Moscow, Russian FederationHuman Stem Cells Institute
Jul 25, 2022